Tatva Chintan Pharma Chem Ltd IPO Message Board (Page 50)

revised as per price band...


Tatva Chintan Pharma Chem IPO – Schedule *(Final – Pg#305 of RHP)*

13th July – Announcement of Price Band
15th July – Anchor Investors Allotment
16th July – Offer Opens
20th July – Offer Closes
26th July – Finalisation of Basis of Allotment
27th July – Unblocking of ASBA Accounts
28th July – Credit of Equity Shares to Depository Accounts
29th July – Commencement of Trading


Tatva Chintan Pharma Chem IPO – Issue Information *(Tentative)*

Issue Opens on: 16 July 2021
Issue Closes on: 20 July 2021
Issue Type: Book Built Issue IPO
Issue Size: 46,16,804 Shares
Face Value: Rs.10/- per Share
Issue Price: Rs.1,073 – Rs.1,083 Share
Discount: NIL
Market Lot: 13 Shares
Listing At: NSE, BSE

Equity Shares outstanding prior to the Issue = 2,00,87,500 Shares
Fresh Issue of 20,77,562 Shares @1,038/- = Rs.225Crs
Offer for Sale of 25,39,242 Shares @1,038/- = Rs.275Crs
Equity Shares outstanding after the Issue = 2,21,65,062 Shares

Category-wise Break up:
Anchor – 13,85,041 Shares = 150.00Crs
QIB – 9,23,361 Shares = 100.00Crs
NII – 6,92,521 Shares = 75.00Crs
RII – 16,15,881 Shares = 175.00Crs (Lot size: 13 = 1,24,299 Forms)
Total Issue – 46,16,804 Shares = 500.00Crs.

Subscription required for 1X
RII = 1,24,299 Forms
NII = 75 Crs


Tatva Chintan Pharma Chem IPO – Financial Information (Basis of Valuation)

The information is collated from the following documents:
1) RHP = Red Herring Prospectus Dated July 10, 2021 (373 pages)

EPS for FY17-18 >>> Rs.06.12 (Page #89 of DRHP)
EPS for FY18-19 >>> Rs.10.23 (Page #96 of RHP)
EPS for FY19-20 >>> Rs.18.81 (Page #96 of RHP)
EPS for FY20-21 >>> Rs.26.02 (Page #96 of RHP)

RoNW for FY17-18 >>> 20.79% (Page #90 of DRHP)
RoNW for FY18-19 >>> 25.78% (Page #97 of RHP)
RoNW for FY19-20 >>> 32.11% (Page #97 of RHP)
RoNW for FY20-21 >>> 31.49% (Page #97 of RHP)

NAV as on March 31, 2021 was Rs.82.62 (Page #97 of 7RHP)

Listed Industry Peer Group (Page #97 of DRHP): Aarti Industries, Navin Fluorine International, Alkyl Amines Chemicals, Vinati Organics, Fine Organics Industries


Tatva Chintan Pharma Chem IPO – *Market’s Current Estimates of oversubscription*:

NII = 20KCrs. = ~266.67X
RII = 20L Forms = 16.09X Applic. wise (Avg allotment of ~0.81 shares per lot)

Interest cost *@8.00%p.a.* for 7days = *166.16paise for 1X*

Thus, for NII the costing = 266.67 X 166.16 paise = Rs.443.09 per share (= GMP)

And, for RII the costing = 443.09 X 0.81 = Rs.358/- (= Kostak)


Tatva Chintan Pharma Chem IPO – *GMP Estimated*

GMP 500 +/- 2
Kostak 400 +/- 10
Subject 2 @5,500/-

Thank you @eagleye madam

,
.

2021
Revenue : 2369.38 ⬇️ yoy
Net profit after tax : 513.59 ⬆️ yoy
Diluted EPS: 25.57 ⬆️ yoy

Mention whether they are in cr or millions or lakhs otherwise it will give a wrong impression on company

Tatva Chintan Pharma Chem IPO – *Market’s Current Estimates of oversubscription*:

NII = 25KCrs. = ~333.33X
RII = 22L Forms = 17.70X Applic. wise (Avg allotment of ~0.73 shares per lot)

Interest cost *@8.00%p.a.* for 7days = *166.16paise for 1X*

Thus, for NII the costing = 333.33 X 166.16 paise = Rs.553.86 per share (= GMP)

And, for RII the costing = 553.86 X 0.73 = Rs.407/- (= Kostak)


Tatva Chintan Pharma Chem IPO – *GMP Estimated*

GMP 575 +/- 2
Kostak 425 +/- 10
Subject 2 @6,350/-

Mobikwik Issue details:

Issue Size - 1900 cr
Fresh Offer - 1500 cr
OFS - 400

Financials: 2019-2020
Revenue: -> 369 cr
Loss: -> 99 cr

Financials: 2020-2021
Revenue: ->302.2 cr
Loss: 111 cr

Major Shareholders:
-> Bipin Preet Singh (founder) - 20.21%
-> Upasana Taku (founder) 14.31%
-> Sequoia Capital India - 17.25%
-> Bajaj Finance - 13.83%
-> Tree Line Asia - 4.43%

Source: https://www.moneycontrol.com/news/business/startup/decoding-mobikwiks-ipo-documents-in-5-charts-7166721.html

GMP IS GOOD THAN ZOMATO

Listing gain expected as per GMP .

470 × 17 = 7990. G R INFRA
500 × 16 = 8000 CLEAN SCIENCE.
540 × 13 =7020 TATVA
.

82 × 195 =1170 Zomato

@Dinesh, here you go.

@crow it is not 82*195 it is 6*195

GMP- 525

Zomato se sabko dar lag raha hai.

FOMO bhi hai kahi moka hath se chhut na jaye or price bhi overvalued lag raha hai. Kahi irfc ki tarah discount listing na ho jaye.

Dosto mujhe lagta hai HNI me bhar bhar ke maal milega risk lene wala hona chahiye.

Guess glenmark RHP not filed yet, so people can still buy 1 share for SH quota

@Newrookie, no. Both retail application and SH application will be treated as separate applications. Similar to how you can apply both as retail and HNI from same PAN. If there had been an employee quota and you were a Glenmark LS employee, you could shoot 3 individual applications. Isn''t Sebi great?

Newrookie

It will not double

Koi bata sakta he number 373 ka raaz

Thank me later

Very useful information indeed

Kya raaz hai 373 ka? Please elaborate. Thnx

Tatva Chintan Pharma Chem IPO – *Market’s Current Estimates of oversubscription*:

NII = 24KCrs. = ~320X
RII = 22L Forms = 17.70X Applic. wise (Avg allotment of ~0.73 shares per lot)

Interest cost *@8.00%p.a.* for 7days = *166.16paise for 1X*

Thus, for NII the costing = 320.00 X 166.16 paise = Rs.531.71 per share (= GMP)

And, for RII the costing = 531,71 X 0.73 = Rs.391/- (= Kostak)


Tatva Chintan Pharma Chem IPO – *GMP Estimated*

GMP 550 +/- 2
Kostak 400 +/- 10
Subject 2 @6,100/-

Tatva Chintan Pharma Chem IPO – *GMP Estimated*

GMP 540 +/- 2
Kostak 435 +/- 10
Subject 2 @6,000/-

540 × 13 = 7020 listing gain expected .

Where is RHP still RHP not out on sebi or book manager site

Why people spread the dates while another ipo is ready to open

Please see ICICI securities site under offer document section

when rhp is filed why sebi not showing on timely manner ?

🌟 Tatva Chintan Pharma Chem Ltd IPO

🔸Basic Details
Opens : 16th July 2021
Closes : 20th July 2021
Price Band : Rs 1073-Rs 1083
Lot : 13 shares
IPO Size: Rs 500Cr
Retail Quota: 35%

🔸Financial Analysis FY 2020-21
EPS: Rs 26.02
Book Value: Rs 82.62
Return On Net worth: 31.49%
PE Ratio: 34.39

🔸GMP Update
GMP :Rs 435 Per Share (Buying side)
Expected Listing Gain:Approx. Rs 5,000 per lot

PE ratio = upper price band / EPS = 1083 / 26.02 = 41.62. How did you come to 34.39 value?

yes. Typo Error
PE ratio is: 41.62x
Here, we cannot edit or Delete after posting mgs.
@Teamchittorgarh please add these features

Sun ne me aaya he ek aur IPO aa raha he glenmark ke siva mrket me

Any Guesses?

Glenmark kab aa raha hai market me

7 Iceland ?

Tatva Chintan Pharma Chem Ltd IPO

Opens : 16th July 2021
Closes : 20th July 2021
Price Band : Rs 1073-Rs 1083
Lot : 13 shares

The issue is coming with PE of 41x

QIB- 50%
NII/HNI- 15%
RII- 35%
Quota

Lot Size- 13

Price Band of Tatva Chintan Pharma - 1073 to 1083rs per share